Decitabine in combination with G-CSF, low-dose cytarabine and aclarubicin is as effective as standard dose chemotherapy in the induction treatment for patients aged from 55 to 69 years old with newly diagnosed acute myeloid leukemia

  • Jiayu Huang, Ming Hong, Yu Zhu, Huihui Zhao, Xiaoyan Zhang, Yujie Wu, Yun Lian, Xiaoli Zhao, Jianyong Li, Sixuan Qian
  • Leukemia & Lymphoma, April 2018, Taylor & Francis
  • DOI: 10.1080/10428194.2018.1443328

The authors haven't yet claimed this publication.

Read Publication

http://dx.doi.org/10.1080/10428194.2018.1443328